Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 10
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case-control study in Canada | Ding Z, Sherlock M, Chan AKC, Zachos M | 2022 | Blood Coagul Fibrinolysis | View Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case-control study in Canada | Researchers | Clinical research |
Assessing unintentional creation of bias against men who have sex with men as a function of exposure to blood donor screening questionnaire: A national randomized controlled trial | Hofkirchner A, Kohut T, O'Brien SF, Fisher WA | 2022 | Transfusion | View Assessing unintentional creation of bias against men who have sex with men as a function of exposure to blood donor screening questionnaire: A national randomized controlled trial | Researchers | MSM research |
Research partnerships between blood services and public health authorities: An international, cross-sectional survey | Lewin A, Osiowy C, Erikstrup C, Custer B, Renaud C, Tiberghien P, Russell A, Lieshout-Krikke R, O'Brien SF, the Surveillance Risk Assessment Policy Sub-group of the ISBT Transfusion Transmitted Infectious Diseases Working Party | 2022 | Vox Sang | View Research partnerships between blood services and public health authorities: An international, cross-sectional survey | Blood operators | Benchmarking and standard setting |
FAQ : Information destinée aux professionnels de la santé concernant les plaquettes à teneur réduite en agents pathogènes | Ning S, Tordon B, Zeller M, Anani W | 2022 | Blood.ca website | View FAQ : Information destinée aux professionnels de la santé concernant les plaquettes à teneur réduite en agents pathogènes | Health care providers | New or improved product or process |
Tips, tricks, and thoughts on the future of prehospital blood transfusions | Yazer MH, Beckett A, Corley J, Devine DV, Studer NM, Taylor AL, Ward KR, Cap AP | 2022 | Transfusion | View Tips, tricks, and thoughts on the future of prehospital blood transfusions | Health care providers | Clinical research |
Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays | Tuite AR, Fisman D, Abe KT, Rathod B, Pasculescu A, Colwill K, Gingras A-C, Yi Q-L, O’Brien SF, Drews SJ, Pride DT | 2022 | Microbiol Spectr | View Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays | Researchers | Basic research |
Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review | Saeed S, Uzicanin S, Lewin A, Lieshout-Krikke R, Faddy H, Erikstrup C, Osiowy C, Seed CR, Steele WR, Davison K, Custer B, O'Brien SF, Assessment SR, Policy Sub-group of the Transfusion Transmitted Infectious Diseases Working Party of the International Society of Blood Transfusion | 2022 | Vox Sang | View Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review | Researchers | Basic research |
Impact of product platelet count reduction on platelet demand in Canada | Devine DV | 2022 | Transfusion | View Impact of product platelet count reduction on platelet demand in Canada | Blood operators | Benchmarking and standard setting |
Risk factors for neonatal thrombosis: A retrospective study conducted in a single Canadian intensive care unit | Bhatia K, Solanki S, Paes B, Chan AKC, Bhatt MD | 2022 | Pediatr Blood Cancer | View Risk factors for neonatal thrombosis: A retrospective study conducted in a single Canadian intensive care unit | Researchers | Clinical research |
Mitapivat versus Placebo for Pyruvate Kinase Deficiency | Al-Samkari H, Galactéros F, Glenthøj A, Rothman JA, Andres O, Grace RF, Morado-Arias M, Layton DM, Onodera K, Verhovsek M, Barcellini W, Chonat S, Judge MP, Zagadailov E, Xu R, Hawkins P, Beynon V, Gheuens S, van Beers EJ | 2022 | N Engl J Med | View Mitapivat versus Placebo for Pyruvate Kinase Deficiency | Researchers | Clinical research |
Chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia | Branch DR, Leger RM, Sakac d, Yi Q, Duong T, Yeung RSM, Binnington B, Bloch EM | 2022 | Blood Adv | View Chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia | Researchers | Basic research |
Directive no 343 réaffirmée : Prédiction du génotype RHD fœtal par test prénatal non invasif de routine | Johnson J-A, MacDonald K, Clarke G, Skoll A | 2022 | J Obstet Gynaecol Can | View Directive no 343 réaffirmée : Prédiction du génotype RHD fœtal par test prénatal non invasif de routine | Health care providers | Benchmarking and standard setting |
Rapid potency assessment of autologous peripheral blood stem cells by intracellular flow cytometry: the PBSC-IL-3-pSTAT5 assay | Simard C, Fournier D, Pineault N, Trépanier P | 2022 | Cytotherapy | View Rapid potency assessment of autologous peripheral blood stem cells by intracellular flow cytometry: the PBSC-IL-3-pSTAT5 assay | Researchers | New or improved product or process |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Health care providers | Benchmarking and standard setting |
Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study | Chornenki NLJ, Siegal DM, Qamar K, Woolgar S, Rangarajan S, Karampatos S, Leong DP, Hillis CM | 2022 | Leuk Res | View Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study | Researchers | Clinical research |
Transfusion of a platelet pool contaminated with exotoxin-producing Staphylococcus aureus: a case report | Chi SI, Kumaran D, Zeller MP, Ramirez-Arcos S | 2022 | Annals of Blood | View Transfusion of a platelet pool contaminated with exotoxin-producing Staphylococcus aureus: a case report | Health care providers | Clinical research |
Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections | Grunau B, Tom J, Asamoah-Boaheng M, O’Brien SF, Drews SJ, Sediqi S, Lavoie PM, Barakauskas V, Goldfarb DM | 2022 | Open Forum Infect Dis | View Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections | Researchers | Basic research |
Emicizumab state-of-the-art update | Mahlangu J, Iorio A, Kenet G | 2022 | Haemophilia | View Emicizumab state-of-the-art update | Health care providers | Clinical research |
ResearchUnit: Sexual behaviour-based screening questions: Understanding and mitigating donor discomfort | Woo H | 2022 | Blood.ca website | View ResearchUnit: Sexual behaviour-based screening questions: Understanding and mitigating donor discomfort | Blood operators | MSM research |
Effect of modern infusion pumps on RBC quality | Hadjesfandiari N, Serrano K, Levin E, Johal P, Feenstra S, Shih AW, Devine DV | 2022 | Transfusion | View Effect of modern infusion pumps on RBC quality | Researchers | Benchmarking and standard setting |
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic | Al-Riyami AZ, Burnouf T, Wood EM, Devine DV, Oreh A, Apelseth TO, Goel R, Bloch EM, van Den Berg K, Getshen M, Louw V, Ang AL, Lee CK, Rahimi-Levene N, Stramer SL, Vassallo R, Schulze TJ, Patidar GK, Pandey HC, Dubey R, Badawi M, Hindawi S, Meshi A, Matsushita T, Sorrentino E, Grubovic Rastvorceva RM, Bazin R, Vermeulen M, Nahirniak S, Tsang HC, Vrielink H, Triyono T, Addas-Carvalho M, He?imovi? A, Torres OW, Mutindu SM, Bengtsson J, Dominguez D, Sayedahmed A, Hanisa Musa R, Gautam B, Herczenik E, So-Osman C, the ISBT COVID-19 Convalescent Plasma Working Group | 2022 | Vox Sang | View International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic | Health care providers | Benchmarking and standard setting |
The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia | Bissola AL, Daka M, Arnold DM, Smith JW, Moore JC, Clare R, Ivetic N, Kelton JG, Nazy I | 2022 | Blood Adv | View The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia | Researchers | Clinical research |
Transfusion-Transmitted Infections | Drews SJ, Dodd RY | 2022 | Practical Transfusion Medicine | View Transfusion-Transmitted Infections | Health care providers | Benchmarking and standard setting |
Understanding the experiences of plasma donors in Canada's new source plasma collection centres during COVID-19: A qualitative study | Holloway K | 2022 | Vox Sang | View Understanding the experiences of plasma donors in Canada's new source plasma collection centres during COVID-19: A qualitative study | Researchers | Ethical, legal & social implications research |
c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance | Li F, Xiong Y, Yang M, Chen P, Zhang J, Wang Q, Xu M, Wang Y, He Z, Zhao X, Huang J, Gu X, Zhang L, Sun R, Sun X, Li J, Ou J, Xu T, Huang X, Cao Y, Xu XR, Karakas D, Li J, Ni H, Zhang Q | 2022 | Cell Death Dis | View c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance | Researchers | Basic research |
Switching from standard to extended half-life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics | Nummi V, Lehtinen AE, Iorio A, Szanto T, Lassila R | 2022 | Haemophilia | View Switching from standard to extended half-life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics | Researchers | Clinical research |
Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era | Reedman CN, Drews SJ, Yi Q-L, Pambrun C, O’Brien SF | 2022 | Microbiol Spectr | View Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era | Researchers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources: Response to Comment from Yamada et al | Greinacher A, Langer F, Makris M, Pai M, Pavord S, Tran H, Warkentin TE | 2022 | J Thromb Haemost | View Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources: Response to Comment from Yamada et al | Health care providers | Clinical research |
Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID-19 pandemic: A Canadian Blood Services Stem Cell Registry analysis | Allan DS, Green M, Morris G, Weiss J, Dibdin N, Mercer D, Seftel M | 2022 | Vox Sang | View Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID-19 pandemic: A Canadian Blood Services Stem Cell Registry analysis | Blood operators | Clinical research |
Risk factors for bleeding in people living with hemophilia A and B treated with regular prophylaxis: A systematic review of the literature | Germini F, Noronha N, Abraham Philip B, Olasupo O, Pete D, Navarro T, Keepanasseril A, Matino D, de Wit K, Parpia S, Iorio A | 2022 | J Thromb Haemost | View Risk factors for bleeding in people living with hemophilia A and B treated with regular prophylaxis: A systematic review of the literature | Researchers | Clinical research |
Reaffirmed Guideline No. 343: Routine Non-Invasive Prenatal Prediction of Fetal RHD Genotype | Johnson J-A, MacDonald K, Clarke G, Skoll A | 2022 | J Obstet Gynaecol Can | View Reaffirmed Guideline No. 343: Routine Non-Invasive Prenatal Prediction of Fetal RHD Genotype | Health care providers | Benchmarking and standard setting |
Mortality and its associated factors in transfused patients at a tertiary hospital in Uganda | Okello CD, Shih AW, Angucia B, Kiwanuka N, Heddle N, Orem J, Mayanja-Kizza H | 2022 | PLoS One | View Mortality and its associated factors in transfused patients at a tertiary hospital in Uganda | Health care providers | Clinical research |
Circular of information for the use of human blood components: Platelets | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Platelets | Health care providers | Benchmarking and standard setting |
Necrotizing enterocolitis and mortality after transfusion of ABO non-identical blood | Parvizian MK, Barty R, Heddle NM, Li N, McDougall T, Mukerji A, Fusch C, Solh Z | 2021 | Transfusion | View Necrotizing enterocolitis and mortality after transfusion of ABO non-identical blood | Researchers | Clinical research |
Mechanism of increased efficacy of recombinant Fc-?TP-L309C compared to IVIg to ameliorate mouse immune thrombocytopenia | Lewis BJB, Binnington B, Blacquiere M, Spirig R, Käsermann F, Branch DR | 2021 | eJHaem | View Mechanism of increased efficacy of recombinant Fc-?TP-L309C compared to IVIg to ameliorate mouse immune thrombocytopenia | Researchers | Basic research |
Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation | Gaussen A, Hornby L, Rockl G, O’Brien S, Delage G, Sapir-Pichhadze R, Drews SJ, Weiss MJ, Lewin A | 2021 | Transplantation | View Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation | Health care providers | Clinical research |
The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters | Choi PY, Grace RF, Therese Ahlen M, Nazy I, Sachs UJ, Arnold DM, McKenzie SE, Althaus K, Sharma R, Bakchoul T | 2021 | J Thromb Haemost | View The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters | Researchers | Benchmarking and standard setting |
ResearchUnit: Intravenous albumin is not associated with improved outcomes in cardiac surgery patients | Bartoszko J | 2021 | Blood.ca website | View ResearchUnit: Intravenous albumin is not associated with improved outcomes in cardiac surgery patients | Health care providers | Clinical research |
Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database | Versloot O, Iserman E, Chelle P, Germini F, Edginton AN, Schutgens REG, Iorio A, Fischer K | 2021 | J Thromb Haemost | View Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database | Researchers | Clinical research |
Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis | Siemieniuk RA, Bartoszko JJ, Díaz Martinez JP, Kum E, Qasim A, Zeraatkar D, Izcovich A, Mangala S, Ge L, Han MA, Agoritsas T, Arnold D, Ávila C, Chu DK, Couban R, Cusano E, Darzi AJ, Devji T, Foroutan F, Ghadimi M, Khamis A, Lamontagne F, Loeb M, Miroshnychenko A, Motaghi S, Murthy S, Mustafa RA, Rada G, Rochwerg B, Switzer C, Vandvik PO, Vernooij RW, Wang Y, Yao L, Guyatt GH, Brignardello-Petersen R | 2021 | BMJ | View Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis | Researchers | Clinical research |
Rapport de surveillance 2020 | O'Brien S | 2021 | Blood.ca website | View Rapport de surveillance 2020 | Health care providers | Benchmarking and standard setting |
Anaphylactic transfusion reactions and IgA deficiency | Khandelwal A, Clarke G, Goldman M | 2021 | Blood.ca website | View Anaphylactic transfusion reactions and IgA deficiency | Health care providers | Benchmarking and standard setting |
Current Understanding of the Relationship between Blood Donor Variability and Blood Component Quality | Hadjesfandiari N, Khorshidfar M, Devine DV | 2021 | Int J Mol Sci | View Current Understanding of the Relationship between Blood Donor Variability and Blood Component Quality | Blood operators | New or improved product or process |
Evidence of SARS-CoV-2 Infection in Cells, Tissues and Organs and the Risk of Transmission Through Transplantation | Gaussen A, Hornby L, Rockl G, O'Brien S, Delage G, Sapir-Pichhadze R, Drews SJ, Weiss MJ, Lewin A | 2021 | Transplantation | View Evidence of SARS-CoV-2 Infection in Cells, Tissues and Organs and the Risk of Transmission Through Transplantation | Health care providers | Clinical research |
International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee | Vishnu P, Duncan J, Connell N, Cooper N, Lim W, Rodeghiero F, Tomiyama Y, Grace RF, Bakchoul T, Arnold DM | 2021 | J Thromb Haemost | View International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee | Health care providers | Benchmarking and standard setting |
How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice | Ting J, Yeung K, Paes B, Chan AKC, Petropoulos JA, Banfield L, Bhatt MD | 2021 | Blood Coagul Fibrinolysis | View How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice | Health care providers | Clinical research |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard | Saeed S, O’Brien SF, Abe K, Yi Q-L, Rathod B, Wang J, Fazel-Zarandi M, Tuite A, Fisman D, Wood H, Colwill K, Gingras A-C, Drews SJ | 2021 | PLoS One | View Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard | Health care providers | Benchmarking and standard setting |
Using Blood Wisely One Year Later – Ontario Hospitals Stepping Up to the Challenge | Day D, Lin Y | 2021 | Ontario Regional Blood Coordinating Network September 2021 Newsletter | View Using Blood Wisely One Year Later – Ontario Hospitals Stepping Up to the Challenge | Health care providers | Benchmarking and standard setting |
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial | Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chassé M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A, Marceau D, Huang A, Carr H, Lin Y, Lall R, Graham C, Arsenault C, Sales V, Sidhu D, Semret M, Hamm C, Arhanchiague E, Solh Z, Srour N, Soliman K, Yee C, Laroche V, Nahirniak S, Greenaway C, Pai M, Côté A, Tsang JLY, Cserti-Gazdewich C, Talbot D, Poulin S, Guimaraes R, Rushton-Marovac M, Langlois A, Ning S, Shih A, Boileau M, Singh H, Ledingham D, Ponnampalam A, Yan M, Prokopchuk-Gauk O, Poirier A, Girouard G, Pavenski K, Drouin O, Harris D, Durand M, Rimmer E, Ovakim D, Ménard F, Cuccarolo G, Carruthers J, Lucier K, Arsenault V, Auclair M-C, Avram M, Brassard M, Cerro S, Martinez V, Morin J, Saint-Jacques M, Veillette M, Armali C, Kron A, Modi D, Duncan J, Justumus P, John MS, St-Onge G, Hadzi-Tosev M, Dion P-M, McGillivary L, de Moulliac AV, Nyman SA, Perilli S, Van Vliet PJ, Lane S, Pavenski K, Pereira R, Sirotich E, Abelson J, Greene S, Khandelwal A, Thakar S, Longo S, Anand SP, Benlarbi M, Bourassa C, Boutin M, Descôteaux-Dinelle J, Gendron-Lepage G, Goyette G, Laumaea A, Medjahed H, Prévost J, Richard J, Kaufmann D, Brunet-Ratnasingham E, Chaumont N, Drebot M, Robinson A, Mendoza E, Dimitrova K, Manguiat K, Phillipson C, Chan M, Evans D, Lin J, Boyer L, Cloutier M, Drouin M, Ducas É, Dussault N, Fournier M-J, Landy P, Nolin M-È, Perreault J, Tremblay T, Nazy I, Xie F, Liu D, Wong M, Silverio G, Walkus K, Barton M, Haveman K, Mueller D, Scott A, Moher M, Wood G, Roarty T, Auld F, Carney G, Thomson V, Onell R, Walley K, Donohoe K, Brunk C, Hernandez G, Jacobucci T, Lazosky L, Mann P, Raval G, Zampieri LA, Sekhon M, Wright A, James N, Chang G, Chen R, Deol K, Gantioqui J, Larsen E, Ramdin N, Roche M, Rosinski K, Sham L, Storms M, Gillrie M, Mahe E, Suryanarayan D, Ugarte-Torres A, Robinson T, Gibbs M, Hewsgirard J, Holmes M, McCarthy J, Ody M, Doucette K, Sligl W, Sonpar A, Robertson K, Narayan J, Ravindran L, Stewart B, Zapernick L, Lee S, Sy E, Wong A, Gryzb K, Craddock S, Fuchs D, Myrah D, Sunny S, Harding SR, Kogilwaimath S, Hodgson N, Johnson D, Meier S, Thomson K, Heendeniya A, Houston B, Kenyan Y, Lother S, Olafson K, Rush B, Wuerz T, Solvason D, Albensi L, Alias S, Choi N, Curtis L, Hutmacher M, Kashani H, Lane D, Marten N, Pronyk-Ward T, Rigaux L, Silva R, Tays Q, Naidu R, Mathews J, Mai M, Miceli V, Molson L, Radhakrishnan G, Schaefer L, Haddad M, Landry S, Chernish R, Kruisselbrink R, Liu T, Jeromin J, Siddiqui A, Girolametto C, Krokoszynski K, Main C, Fox-Robichaud A, Rochwerg B, Kruja E, Ellingham D, Sampat D, Tang N, Leto D, Karunakaran M, Ricciuto D, Fusco K, Ghate T, Robinson H, Ball I, Shalhoub S, Slessarev M, Silverman M, Nano E, Bentall T, Campbell E, Kinney J, Parvathy S, Fera E, Delfa AL, Nadarajah J, Solow H, Mendoza E, Engel K, Monaco D, Kononow L, Suntharalingam S, Fralick M, Munshi L, Saeed S, Hajjaj O, Hsu E, Ali K, Duan E, Farjou G, Jenson L, Salib M, Patterson L, Anant S, Ding J, Jomy J, Das P, Geagea A, the Concor-Study Group | 2021 | Nat Med | View Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial | Health care providers | Clinical research |
Diagnostic approach to the adult with unexplained thrombocytopenia | Arnold D, Cuker A | 2021 | UptoDate | View Diagnostic approach to the adult with unexplained thrombocytopenia | Health care providers | Benchmarking and standard setting |